Instituto de Investigación Biomédica de Salamanca clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Minor: Physical Exercise Prescription Program in Primary Care for Adults Aged 65 and Older: PREFIS-AP Primary completion pushed from Oct 2026 to Dec 2026
- Notable: Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors Recruitment opened
- Notable: TER-EYE · Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments Primary completion pushed from Jun 2027 to Jan 2029
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
Not charted: 12 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Non-Hodgkin Lymphoma (3) · Heart Disease (2) · Chronic Kidney Disease (1) · Colorectal Cancer (1) · Coronary Artery Disease (1) · DLBCL (1) · Lung Cancer (1) · Myelodysplastic Syndromes (MDS) (1) · Small Cell Lung Cancer (1)
Get alerts when Instituto de Investigación Biomédica de Salamanca's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.